REQUEST A DEMO
Total
USD $0.00
Search more companies

Arbofarma S.A.S (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Arbofarma S.A.S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Arbofarma S.A.S is an enterprise in Colombia, with the main office in Bogota D.C.. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on June 08, 2000. It currently has a total number of 165 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 37.14% in 2023. Its’ total assets recorded a growth of 37.58%. The net profit margin of Arbofarma S.A.S increased by 5.22% in 2023.

Headquarters
Calle 20A No 43A - 50 Interior 6
Bogota D.C.; Bogota D.C; Postal Code: 0607

Contact Details: Purchase the Arbofarma S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Arbofarma S.A.S report to view the information.
Outstanding Shares:
Purchase the Arbofarma S.A.S report to view the information.
Registered Capital:
Purchase the Arbofarma S.A.S report to view the information.
Incorporation Date:
June 08, 2000
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Arbofarma S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
37.14%
Total operating revenue
37.3%
Operating profit (EBIT)
77.28%
EBITDA
72.75%
Net Profit (Loss) for the Period
73.93%
Total assets
37.58%
Total equity
15.04%
Operating Profit Margin (ROS)
8.63%
Net Profit Margin
5.22%
Return on Equity (ROE)
24%
Debt to Equity Ratio
-13.8%
Quick Ratio
3%
Cash Ratio
1.92%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?